Outcomes in children with vesicoureteral reflux receiving antibiotic prophylaxis
dc.contributor.author | Tompkins, Madeline G. | |
dc.contributor.author | Kussin, Michelle | |
dc.contributor.author | Christenson, John C. | |
dc.contributor.author | Boyd, LaKeisha | |
dc.contributor.author | Tat, Kiet | |
dc.contributor.author | Schneider, Jack G. | |
dc.contributor.author | Han, Rachel T. | |
dc.contributor.department | Pediatrics, School of Medicine | |
dc.date.accessioned | 2025-03-25T11:49:14Z | |
dc.date.available | 2025-03-25T11:49:14Z | |
dc.date.issued | 2025-02-12 | |
dc.description.abstract | Antibiotic prophylaxis in children with vesicoureteral reflux (VUR) remains controversial. We reviewed patients diagnosed with VUR after an index urinary tract infection (UTI) who subsequently received antibiotic prophylaxis. Recurrent UTIs in patients with and without urologic anomalies occurred in 57% and 33%, respectively. Multidrug-resistant organisms accounted for 25% of first UTI recurrences. | |
dc.eprint.version | Final published version | |
dc.identifier.citation | Tompkins MG, Kussin M, Christenson JC, et al. Outcomes in children with vesicoureteral reflux receiving antibiotic prophylaxis. Antimicrob Steward Healthc Epidemiol. 2025;5(1):e30. Published 2025 Feb 12. doi:10.1017/ash.2024.497 | |
dc.identifier.uri | https://hdl.handle.net/1805/46571 | |
dc.language.iso | en_US | |
dc.publisher | Cambridge University Press | |
dc.relation.isversionof | 10.1017/ash.2024.497 | |
dc.relation.journal | Antimicrobial Stewardship & Healthcare Epidemiology | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | en |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.source | PMC | |
dc.subject | Antibiotic prophylaxis | |
dc.subject | Vesicoureteral reflux (VUR) | |
dc.subject | Urinary tract infection (UTI) | |
dc.title | Outcomes in children with vesicoureteral reflux receiving antibiotic prophylaxis | |
dc.type | Article |